絞り込み

16507

広告

Metabolic Regulation in Mitochondria and Drug Resistance.

著者 Pan Y , Cao M , Liu J , Yang Q , Miao X , Go VLW , Lee PWN , Xiao GG
Adv Exp Med Biol.2017 ; 1038():149-171.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (24view , 0users)

Full Text Sources

Mitochondria are generally considered as a powerhouse in a cell where the majority of the cellular ATP and metabolite productions occur. Metabolic rewiring and reprogramming may be initiated and regulated by mitochondrial enzymes. The hypothesis that cellular metabolic rewiring and reprogramming processes may occur as cellular microenvironment is disturbed, resulting in alteration of cell phenotype, such as cancer cells resistant to therapeutics seems to be now acceptable. Cancer metabolic reprogramming regulated by mitochondrial enzymes is now one of the hallmarks of cancer. This chapter provides an overview of cancer metabolism and summarizes progress made in mitochondria-mediated metabolic regulation in cancer drug resistance.
PMID: 29178075 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード